Purchases and Sales Made in Q4 2023 in Nautilus Biotechnology, Inc. (NAUT)
This table provides information about the institutional ownership of Nautilus Biotechnology, Inc. (NAUT) during Q4 2023. The information is specifically focused on institutions that hold shares of Nautilus Biotechnology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Alyeska Investment Group, L.P.
Chicago, IL |
SELL
|
- |
-4.97K- 1.11% |
$11.6K - $16.8K
|
441K
$393K
|
|
|
Feb 05, 2024
Q4 2023
|
Vanguard Capital Wealth Advisors
|
SELL
|
- |
-6K- 13.04% |
$14K - $20.3K
|
40K
$35.6K
|
|
|
Jan 25, 2024
Q4 2023
|
Nisa Investment Advisors, LLC
|
SELL
|
- |
-8.97K- 99.83% |
$21K - $30.4K
|
15
$13.4
|
|
|
Feb 06, 2024
Q4 2023
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-9.12K- 6.27% |
$21.4K - $30.9K
|
136K
$121K
|
|
|
May 21, 2024
Q4 2023
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
SELL
|
- |
-9.62K- 39.97% |
$22.5K - $32.6K
|
14.5K
$12.9K
|
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-13.7K- 16.94% |
$32K - $46.3K
|
67K
$59.6K
|
|
|
Feb 14, 2024
Q4 2023
|
Clearline Capital LP
New York, NY |
SELL
|
- |
-30.2K- 11.4% |
$70.7K - $102K
|
235K
$209K
|